PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.
SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025.
AngioDynamics, Inc. ( ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDT Good morning, and welcome to the AngioDynamics Fiscal Year 2026 Third Quarter Earnings Call. [Operator Instructions] As a ...
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were ...
Inspire Medical Systems INSP is well-positioned for solid growth over the next few quarters as it navigates a significant ...
Recently, a reader gave me the idea to search for and make a list of work at home jobs that offer sign-on bonuses. I tho ...
An Antwerp court supports India's extradition request for fugitive Mehul Choksi, dismissing his abduction claims and asylum ...
For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...
Plus Therapeutics (PSTV) receives AMA CPT code for CNSide test, improving reimbursement pathways and clinical adoption amid 4 ...
In an AI-native workflow, the audience for your error messages is an LLM, not a human. Compare "invalid query parameter name ...
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose ...